retatrutide clinical benefits VisualAbstract: reduces body weight by 17.5% in patients with obesity retatrutide benefits clinical trial Results:

[DOI] [PMC free article] [PubMed] [Google Scholar] 60.Mehdi S.F., Pusapati S., Anwar M.S., Lohana D., Kumar P., Nandula S.A., Nawaz F.K., Tracey K., Yang H., LeRoith D., et al

You wont see anyone whos Black

Cost is consideration ($1,200-1,400/month projected)

Alexander Shapsis

Silva specializes in evidence-based weight management and routinely manages GLP-1 therapy and related digestive side effects for patients at Potere Health MD in St

Moreover, efpeglenatide therapy reduced the risk of CV disease by about 27% compared to the placebo in the Effect of Efpeglenatide on Cardiovascular Outcomes (AMPLITUDE-O) study [51]